These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 33142883)
21. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972 [TBL] [Abstract][Full Text] [Related]
22. Predictors of hepatitis B vaccination in women prisoners in two prisons in England. Plugge EH; Yudkin PL; Douglas N J Public Health (Oxf); 2007 Dec; 29(4):429-33. PubMed ID: 17878212 [TBL] [Abstract][Full Text] [Related]
23. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico. Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Rodríguez-Ramírez S; Sierra-Madero J; Beyrer C AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis B vaccine coverage in short and long stay prisons in Wales, UK 2013-2017 and the impact of the global vaccine shortage. Perrett SE; Cottrell S; Shankar AG Vaccine; 2019 Aug; 37(35):4872-4876. PubMed ID: 31362822 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis B vaccination in prisons: the Catalonian experience. Bayas JM; Bruguera M; Martin V; Vidal J; Rodes J; Salleras LY Vaccine; 1993 Nov; 11(14):1441-4. PubMed ID: 8310764 [TBL] [Abstract][Full Text] [Related]
26. Viral hepatitis B, C and HIV infection in Croatian prisons. Burek V; Horvat J; Butorac K; Mikulić R Epidemiol Infect; 2010 Nov; 138(11):1610-20. PubMed ID: 20202285 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates. Izquierdo L; Mellon G; Buchaillet C; Fac C; Soutière MP; Pallier C; Dulioust A; Roque-Afonso AM PLoS One; 2019; 14(6):e0218482. PubMed ID: 31242210 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis B in prisons. Bader TF Biomed Pharmacother; 1986; 40(7):248-51. PubMed ID: 3814756 [TBL] [Abstract][Full Text] [Related]
29. HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France. Rotily M; Vernay-Vaisse C; Bourlière M; Galinier-Pujol A; Rousseau S; Obadia Y Int J STD AIDS; 1997 Dec; 8(12):753-9. PubMed ID: 9433949 [TBL] [Abstract][Full Text] [Related]
30. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients. Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis B vaccination in prisons. Awofeso N Bull World Health Organ; 2002; 80(7):569-74. PubMed ID: 12163921 [TBL] [Abstract][Full Text] [Related]
32. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712 [TBL] [Abstract][Full Text] [Related]
33. Is there room for general practice in penitentiary institutions: screening and vaccinating high-risk groups against hepatitis. Chatziarsenis M; Miyakis S; Faresjo T; Trell E; Vlachonikolis J; Lionis C Fam Pract; 1999 Aug; 16(4):366-8. PubMed ID: 10493706 [TBL] [Abstract][Full Text] [Related]
34. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Pallás JR; Fariñas-Alvarez C; Prieto D; Delgado-Rodríguez M Eur J Epidemiol; 1999 Sep; 15(8):699-704. PubMed ID: 10555612 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey. Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496 [TBL] [Abstract][Full Text] [Related]
36. [Prevalence of hepatitis B and C among prison population in Croatia]. Burek V; Horvat J; Susić E; Mikulić R Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906 [TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of hepatitis B virus infection and associated factors among prison inmates in state of Mato Grosso do Sul, Brazil. Stief AC; Martins RM; Andrade SM; Pompilio MA; Fernandes SM; Murat PG; Mousquer GJ; Teles SA; Camolez GR; Francisco RB; Motta-Castro AR Rev Soc Bras Med Trop; 2010; 43(5):512-5. PubMed ID: 21085860 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650 [TBL] [Abstract][Full Text] [Related]
39. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates. Jacobs RJ; Rosenthal P; Meyerhoff AS Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653 [TBL] [Abstract][Full Text] [Related]
40. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain]. Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]